Canlyniadau Chwilio - Matthieu Texier

  • Dangos 1 - 9 canlyniadau o 9
Mireinio'r Canlyniadau
  1. 1
    Intratumoral Immunotherapy: From Trial Design to Clinical Practice

    Intratumoral Immunotherapy: From Trial Design to Clinical Practice gan Stéphane Champiat, Lambros Tselikas, Siham Farhane, Thibault Raoult, Matthieu Texier, Émilie Lanoy, Christophe Massard, Caroline Robert, Samy Ammari, Thierry de Baère, Aurélien Marabelle

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias

    Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking... gan Maria Kfoury, Marie Najean, Ariane Lappara, Anne-Laure Voisin, Stéphane Champiat, Jean‐Marie Michot, Salim Laghouati, Caroline Robert, Benjamin Besse, Jean‐Charles Soria, Olivier Lambotte, Christophe Massard, Aurélien Marabelle, Matthieu Texier

    Cyhoeddwyd 2022
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

    The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography gan Yohann Loriot, Matthieu Texier, Stéphane Culine, Aude Fléchon, Antoine Thiery-Vuillemin, Gwénaëlle Gravis, L. Geoffrois, Christine Chevreau, Marine Gross‐Goupil, Philippe Barthélémy, Emmanuelle Bompas, Hakim Mahammedi, Brigitte Laguerre, Sophie Abadie Lacourtoisie, Carole Hélissey, Sylvain Ladoire, Christine Abraham, Christophe Massard, Séréna Grimaldi, Karim Fizazi

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer

    An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer gan Antonin Lévy, Daphné Morel, Matthieu Texier, Roger Sun, Jérôme Durand-Labrunie, María E. Rodríguez-Ruiz, S. Racadot, S. Supiot, Nicolas Magné, Stacy Cyrille, G. Louvel, Christophe Massard, Loïc Verlingue, Fanny Bouquet, Alberto Bustillos, Lisa Bouarroudj, Clément Quevrin, Céline Clémenson, Michele Mondini, Lydia Meziani, Lambros Tsélikas, Rastilav Bahleda, Antoine Hollebecque, Éric Deutsch

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy

    Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy gan Roberto Ferrara, Marie Naigeon, Édouard Auclin, Boris Duchemann, Lydie Cassard, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Aude Desnoyer, Laura Mezquita, Matthieu Texier, Caroline Caramella, Lizza Hendriks, David Planchard, Jordi Remón, Sabina Sangaletti, Claudia Proto, Marina Chiara Garassino, Jean‐Charles Soria, Aurélien Marabelle, Anne-Laure Voisin, Siham Farhane, Benjamin Besse, Nathalie Chaput

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

    Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy gan Roberto Ferrara, Laura Mezquita, Matthieu Texier, J. Lahmar, Clarisse Audigier-Valette, Laurent Tessonnier, Julien Mazières, Gérard Zalcman, Solenn Brosseau, Sylvestre Le Moulec, Laura Leroy, Boris Duchemann, Corentin Lefebvre, Rémi Veillon, Virginie Westeel, Serge Koscielny, Stéphane Champiat, Charles Ferté, David Planchard, Jordi Remón, Marie‐Eve Boucher, Anas Gazzah, Julien Adam, Emilio Bria, Giampaolo Tortora, Jean‐Charles Soria, Benjamin Besse, Caroline Caramella

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE 15): a randomised, phase 3 study

    Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE... gan Diane Goèré, Olivier Gléhen, François Quénet, Jean‐Marc Guilloit, Jean-Marc Béréder, G. Lorimier, Emilie Thibaudeau, Laurent Ghouti, Amandine Pinto, Jean‐Jacques Tuech, Réza Kianmanesh, Michel Carretier, Frédéric Marchal, C. Arvieux, Cécile Brigand, Pierre Méeus, Patrick Rat, Sylvaine Durand‐Fontanier, Pascale Mariani, Zaher Lakkis, Valeria Loi, N. Pirró, Charles Sabbagh, Matthieu Texier, Dominique Élias, Michel Ducreux, David Malka, Valérie Boige, E Benhamou

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non–Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy

    Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non–Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy gan Roberto Ferrara, Laura Mezquita, Matthieu Texier, J. Lahmar, Clarisse Audigier-Valette, Laurent Tessonnier, Julien Mazières, Gérard Zalcman, Solenn Brosseau, Sylvestre Le Moulec, Laura Leroy, Boris Duchemann, Corentin Lefebvre, Rémi Veillon, Virginie Westeel, Serge Koscielny, Stéphane Champiat, Charles Ferté, David Planchard, Jordi Remón, Marie Eve Boucher, Anas Gazzah, Julien Adam, Giuseppe Lo Russo, Diego Signorelli, Marina Chiara Garassino, Jean Charles Soria, Caroline Caramella, Benjamin Besse

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

    Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers gan Capucine Baldini, François‐Xavier Danlos, Andreea Varga, Matthieu Texier, Heloise M. Halse, Séverine Mouraud, Lydie Cassard, Stéphane Champiat, Nicolas Signolle, Perrine Vuagnat, Patricia Martín-Romano, Jean‐Marie Michot, Rastislav Bahleda, Anas Gazzah, Lisa Boselli, Delphine Bredel, Jonathan Grivel, Chifaou Mohamed-Djalim, Guillaume Escriou, Laetitia Grynszpan, Amélie Bigorgne, Saloomeh Rafie, Alae Abbassi, Vincent Ribrag, Sophie Postel‐Vinay, Antoine Hollebecque, Sandrine Susini, Siham Farhane, Ludovic Lacroix, Aurélien Parpaleix, Salim Laghouati, Laurence Zitvogel, Julien Adam, Nathalie Chaput, Jean‐Charles Soria, Christophe Massard, Aurélien Marabelle

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: